Journal of Otolaryngology and Ophthalmology of Shandong University ›› 2024, Vol. 38 ›› Issue (1): 27-31.doi: 10.6040/j.issn.1673-3770.0.2022.440

• Original Article • Previous Articles     Next Articles

To analyze the mortality trend of nasopharyngeal carcinoma based on Joinpoint regression and an age-period-cohort model

DAI Honglei1, WANG Qiuyang2, MA Wenxue1, GUAN Bin1, QI Jingjing1   

  1. 1. Department of Otolaryngology, Jingmen People's Hospital, Jingchu Institute of Technology Affiliated Central Hospital, Jingmen 448000, Hubei, China2. Department of Otolaryngology, Xiangyang No.1 People's Hospital, Hubei University of Medicine, Xiangyang 441000, Hubei, China
  • Published:2024-01-12

PDF (PC)

160

Abstract: Objective To explore the long-term development trend of nasopharyngeal carcinoma mortality in China from 1990 to 2019. Methods Data obtained from the GHDx database established by the Global Burden of Disease Project was analyzed in this study. The Joinpoint regression model was used to analyze the trend of NPC mortality in China, and the age-period-cohort model was used to estimate the age effect, period effect, and cohort effect on nasopharyngeal carcinoma mortality risk in China. Results Overall, from 1990 to 2019, the nasopharyngeal carcinoma mortality rate in China showed a downward trend year by year. The Joinpoint regression model showed that the overall trend was divided into five segments, and the AAPC value was -2.454%. The trend of nasopharyngeal carcinoma mortality in males could be divided into five segments, with an AAPC value of -1.958%. The change trend of female nasopharyngeal carcinoma mortality can be divided into six segments, and the AAPC value was -3.498%. Additionally, increasing age significantly increases nasopharyngeal carcinoma mortality, and the cycle effect of mortality generally shows an upward trend. Conclusion The cohort reduction effect may lead to a decrease in nasopharyngeal carcinoma mortality, while an increase in age and the cycle effect may lead to an increase in cancer mortality.

Key words: Nasopharyngeal carcinoma, Mortality, Joinpoint regression model, Age-period-ohort model

CLC Number: 

  • R739.6
[1] 陈万青, 郑荣寿, 张思维, 等. 2012年中国恶性肿瘤发病和死亡分析[J]. 中国肿瘤, 2016, 25(1): 1-8. doi:10.11735/j.issn.1004-0242.2016.01.A001 CHEN Wanqing, ZHENG Rongshou, ZHANG Siwei, et al. Report of cancer incidence and mortality in China, 2012[J]. China Cancer, 2016, 25(1): 1-8. doi:10.11735/j.issn.1004-0242.2016.01.A001
[2] Chen WQ, Zheng RS, Zhang SW, et al. Report of incidence and mortality in China Cancer Registries, 2008[J]. Chinese Journal of Cancer Research, 2012, 24(3): 171-180. doi:10.1007/s11670-012-0171-2
[3] 孙盼盼, 刘莉, 平智广, 等. 不同地区癌症发病分布特征及聚类分析[J]. 中国癌症杂志, 2016, 26(6): 499-507. doi:10.19401/j.cnki.1007-3639.2016.06.004 SUN Panpan, LIU Li, PING Zhiguang, et al. The exploration of characteristics of cancer incidence in cancer surveillance areas by correspondence analysis and cluster analysis[J]. China Oncology, 2016, 26(6): 499-507. doi:10.19401/j.cnki.1007-3639.2016.06.004
[4] Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA: A Cancer Journal for Clinicians, 2021, 71(3): 209-249. doi:10.3322/caac.21660
[5] 陆海军, 刘霁, 丁晓. 鼻咽癌的综合治疗研究进展[J]. 山东大学耳鼻喉眼学报, 2019, 33(2): 26-30. doi:10.6040/j.issn.1673-3770.1.2019.010 LU Haijun, LIU Ji, DING Xiao. Progress in the comprehensive treatment for nasopharyngeal carcinoma[J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2019, 33(2): 26-30. doi:10.6040/j.issn.1673-3770.1.2019.010
[6] 周宇翔, 苗北平,卢永田.首诊鼻咽癌内镜手术的治疗进展[J].山东大学耳鼻喉眼学报, 2021. 35(6): 108-112. doi: 10.6040 / j.issn.1673-3770.0.2020.49 ZHOU Yuxiang, MIAO Beiping, LU Yongtian. Treatment progress of endoscopic surgery for first diagnosed nasopharyngeal carci-noma[J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2021, 35(6): 108-112. doi: 10.6040 / j.issn.1673-3770.0.2020.49
[7] Chen YP, Chan ATC, Le QT, et al. Nasopharyngeal carcinoma[J]. Lancet, 2019, 394(10192): 64-80. doi:10.1016/s0140-6736(19)30956-0
[8] Hongmei, Zeng, PhD, et al. Changing cancer survival in China during 2003-15: a pooled analysis of 17 population-based cancer registries[J]. The Lancet Global Health, 2018, 6(5): e555-e567. doi:10.1016/S2214-109X(18)30127-X
[9] Amin MB, Greene FL, Edge SB, et al. The Eighth Edition AJCC Cancer Staging Manual: continuing to build a bridge from a population-based to a more “personalized” approach to cancer staging[J]. CA: A Cancer Journal for Clinicians, 2017, 67(2): 93-99. doi:10.3322/caac.21388
[10] 刘晓雪, 张志将, 宇传华. 中国居民1987~2015年鼻咽癌死亡趋势[J]. 中南大学学报(医学版), 2018, 43(7): 760-766. doi:10.11817/j.issn.1672-7347.2018.07.010 LIU Xiaoxue, ZHANG Zhijiang, YU Chuanhua. Mortality trend in nasopharynx cancer in Chinese resident from 1987 to 2015[J]. Journal of Central South University(Medical Science), 2018, 43(7): 760-766. doi:10.11817/j.issn.1672-7347.2018.07.010
[11] 项鑫, 王乙. 中国人口老龄化现状、特点、原因及对策[J]. 中国老年学杂志, 2021, 41(18): 4149-4152. doi:10.3969/j.issn.1005-9202.2021.18.072 XIANG Xin, WANG Yi. The present situation, characteristics, causes and countermeasures of population aging in China[J]. Chinese Journal of Gerontology, 2021, 41(18): 4149-4152. doi:10.3969/j.issn.1005-9202.2021.18.072
[12] Aussem A, Morais SR, Corbex M. Analysis of nasopharyngeal carcinoma risk factors with Bayesian networks[J]. Artificial Intelligence in Medicine, 2012, 54(1): 53-62. doi:10.1016/j.artmed.2011.09.002
[13] Lourembam DS, Singh AR, Sharma TD, et al. Evaluation of risk factors for nasopharyngeal carcinoma in a high-risk area of India, the northeastern region[J]. Asian Pacific Journal of Cancer Prevention, 2015, 16(12): 4927-4935. doi:10.7314/apjcp.2015.16.12.4927
[14] Jia WH, Qin HD. Non-viral environmental risk factors for nasopharyngeal carcinoma: a systematic review[J]. Seminars in Cancer Biology, 2012, 22(2): 117-126. doi:10.1016/j.semcancer.2012.01.009
[15] 何朝光, 傅万凯, 陈彩霞, 等. 1990和2017年中国鼻咽癌疾病负担及其趋势[J]. 海峡预防医学杂志, 2020, 26(4): 108-110 HE Chaoguang, FU Wankai, CHEN Caixia, et al. The disease burden and trend of nasopharyngeal carcinoma in China in 1990 and 2017[J]. Strait Journal of Preventive Medicine, 2020, 26(4): 108-110
[16] 魏矿荣, 梁智恒, 欧志雄. 广东省中山市1970~2010年鼻咽癌死亡概况[J]. 中国癌症杂志, 2014, 24(4): 241-245. doi:10.3969/j.issn.1007-3969.2014.04.001 WEI Kuangrong, LIANG Zhiheng, OU Zhixiong. Zhongshan nasopharyngeal carcinoma(NPC)mortality in 1970-2010[J]. China Oncology, 2014, 24(4): 241-245. doi:10.3969/j.issn.1007-3969.2014.04.001
[17] 邹艳花, 廖先珍, 许可葵, 等. 2009~2012年湖南省肿瘤登记地区鼻咽癌的发病与死亡分析[J]. 实用预防医学, 2016, 23(12): 1415-1418. doi:10.3969/j.issn.1006-3110.2016.12.003 ZOU Yanhua, LIAO Xianzhen, XU Kekui, et al. Analysis of incidence and death of nasopharyngeal carcinoma in tumor registration areas of Hunan Province from 2009 to 2012[J]. Practical Preventive Medicine, 2016, 23(12): 1415-1418. doi:10.3969/j.issn.1006-3110.2016.12.003
[18] 容敏华, 李秋林, 曹骥, 等. 2013年广西肿瘤登记地区鼻咽癌发病和死亡分析[J]. 中国癌症防治杂志, 2017, 9(2): 104-110. doi:10.3969/j.issn.1674-5671.2017.02.05 RONG Minhua, LI Qiulin, CAO Ji, et al. Nasopharyngeal cancer incidence and mortality in Guangxi in 2013[J]. Chinese Journal of Oncology Prevention and Treatment, 2017, 9(2): 104-110. doi:10.3969/j.issn.1674-5671.2017.02.05
[19] 赵平,孔灵芝. 中国肿瘤死亡报告: 全国第三次死因回顾抽样调查[M]. 北京: 人民卫生出版社, 2010: 170-187
[1] TU Qiaoling, LI Yufeng, PENG Jun. Advances in anti-PD-L1/PD-1 therapy and non-coding RNA regulation in nasopharyngeal carcinoma [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2023, 37(5): 135-141.
[2] LIU Jiayu, FAN Huiming, ZOU You, CHEN Shiming. Research progress on the application of artificial intelligence in the diagnosis and treatment of nasopharyngeal carcinoma [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2023, 37(2): 135-142.
[3] REN Jia, LÜ Dan, ZHANG Yin, SUN Jiali, MA Lan, ZHENG Yitao, YANG Jimin, YU Lingyu, LI Bo. Application of combining fiberoptic endoscopic evaluation of swallowing technology and swallowing quality of life scale in patients with dysphagia after chemoradiotherapy for nasopharyngeal carcinoma [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2022, 36(6): 83-88.
[4] HUA Hongli, LI Song,TAO Zezhang. Research progress of artificial intelligence in the diagnosis and treatment of nasopharyngeal carcinoma [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2022, 36(2): 113-119.
[5] ZHOU Yuxiang,MIAO Beiping, LU Yongtian. Treatment progress of endoscopic surgery for first diagnosed nasopharyngeal carcinoma [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2021, 35(6): 108-112.
[6] WANG Zhongwei, YANG Lin, GUO Ya, SUN Bin, WANG Yali, MA Xiulong, REN Hongtao, BAO Xing. Analysis of the relationship between miR-429 and miR-200C expression and prognosis in patients with nasopharyngeal carcinoma [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2021, 35(3): 81-86.
[7] TAN Yufang, YI Tianhua. Clinical characteristics and prognosis of sudden sensorineural hearing loss in post-irradiated nasopharyngeal carcinoma survivors: a report of 18 cases [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2021, 35(1): 35-39.
[8] FAN Li, LI Yue, XU Ximing. Changes in and prognostic value of the inflammatory index before and after concurrent chemoradiotherapy for nasopharyngeal carcinoma [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2020, 34(6): 36-41.
[9] The objective of this study was to analyze the effects and possible regulatory mechanisms that Notch receptors could have on cisplatin resistance, observed in nasopharyngeal carcinoma. MethodsWestern blot analysis was used for the detection of Notch receptor expression in nasopharyngeal carcinoma cells and cisplatin-resistant nasopharyngeal carcinoma cells(5-8F, 5-8F/CDDP). Flow cytometry was used to investigate how the combined treatment with 10 μM CDDP and different concentrations of γ-secretase inhibitor(DAPT)could affect apoptosis in 5-8F/CDDP cells. Flow cytometry was also used for the detection of cell cycle stages in DAPT-treated 5-8F / CDDP cells. Finally, western blotting was also used for the detection of drug resistance-related protein expression. All experiments were followed by statistical data analysis. ResultsWe observed significantly higher Notch1 and Notch4 receptor expression in 5-8F/CDDP cells than in 5-8F cells(P=0.003, P=0.004). Furthermore, we described that Notch signaling was inhibited by DAPT in 5-8F/CDDP cells, followed by a significant increase in the apoptosis rate and decrease in cell proliferation, induced by cisplatin in a dose-dependent manner(P<0.05). Moreover, after inhibiting the Notch signaling pathway in 5-8F/CDDP cells, DAPT treatment significantly decreased the expression of Cyclin E and CDK-2, proteins involved in cell cycle regulation, and contributed to blocking the cells in the G1/S phase(P<0.05). At the same time, the expression levels of both the EMT-related protein Slug and the DNA excision repair protein ERCC1 significantly decreased, while that of E-Cadherin was up-regulated. ConclusionUp-regulated expression of Notch1 and Notch4 receptors is associated with cisplatin resistance in nasopharyngeal carcinoma cells. The inactivation of the Notch signaling pathway might thus have the potential to enhance the efficiency of cisplatin chemotherapy in drug-resistant nasopharyngeal carcinoma cells by inhibiting EMT rather than blocking the G1/S cell cycle phase.. Cisplatin resistance in nasopharyngeal carcinoma cells is affected by Notch receptors through the regulation of epithelial-mesenchymal transition rather than cell cycle controlHAN Jibo, ZOU You, YANG Rui, TAO Zezhang Department of Otolaryngology-Head and Neck Surgery, Renmin Hospital of Wuhan University, Wuhan 430060, Hubei, ChinaAbstract:Objective〓 [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2020, 34(4): 105-110.
[10] CHEN Xuesong, FU Weiwei, LIU Jiangtao. The prognostic value of neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in intensity modulated radiation therapy for nasopharyngeal carcinoma [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2020, 34(1): 50-53.
[11] ZHANG Jianli, CHEN Weixiong, CHEN Ruikai, KUANG Debing, PANG Yishi. Evaluation of the effect of fiberoptic endoscopic evaluation of swallowing on long-term survivor with nasopharyngeal cancer [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2019, 33(6): 56-59.
[12] Lin LI,Heng ZHANG,Yufei XIAN,Xiaoli SHENG. Expression and biological function of long chain non-coding cytoskeleton regulator RNA in nasopharyngeal carcinoma [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2019, 33(5): 69-72.
[13] ZHANG Caixia, LIU Yangyun, JIANG Wen, LIU Gengxun, CAO Hang, CHEN Qiong, ZHANG Jishuai. Investigation of chemosensitization induced by nitric oxide on nasopharyngeal carcinoma CNE-2 cells. [J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2017, 31(5): 72-78.
[14] ZHOU Yibo, GONG Xiaorong, YU Feng. Effects of miR-150 targeted to Nanog on proliferation and invasion of nasopharyngeal carcinoma side population cells. [J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2017, 31(5): 79-84.
[15] DU Zhihong. Application of oro-nasal combination approach under electronic nasopharyngoscope in the nasopharyngeal biopsy. [J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2017, 31(4): 117-118.
Viewed
Full text


Abstract

Cited
  Shared   
  Discussed   
No Suggested Reading articles found!
Website Copyright: Editorial Office of Journal of Otolaryngology and Ophthalmology of Shandong University
Address: No.27 Shanda South Road, Jinan, Shandong, China. Post code: 250100 Tel: +86-0531-88366912 Email: ebhxb@sdu.edu.cn Supported by Beijing Magtech Co.Ltd